Last reviewed · How we verify
NCT06096805
Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)
trial in Fetal Growth Retardation in 2,000 participants. Currently enrolling.
30 December 2025
Quick facts
| Lead sponsor | Shanghai First Maternity and Infant Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 10 August 2023 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across China |
Conditions studied
- Fetal Growth Retardation — all drugs for Fetal Growth Retardation →
Sponsor
Shanghai First Maternity and Infant Hospital
Who can join
Adults 18 to 45, female only, with Fetal Growth Retardation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort. By combining maternal basic characteristics, medical history, early pregnancy ultrasound, and biological markers, we aim to construct a joint predictive model for MVM-FGR.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06096805
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fetal Growth Retardation
Currently open trials in the same condition.
- NCT06952777 — Validation of Sensors for Long-term Non-Invasive Fetal Monitoring · NA · recruiting
- NCT06405360 — DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and Development · NA · active not recruiting
- NCT06215690 — Evaluation of Anterior Middle Brain Structures With Cerebrovascular Flow in Fetuses With Fetal Growth Restriction · active not recruiting
- NCT06416995 — Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes · recruiting
- NCT05952583 — Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation · recruiting
Other Shanghai First Maternity and Infant Hospital trials
Trials by the same sponsor.
- NCT07426146 — Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan · recruiting
- NCT06093984 — Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders · NA · not yet recruiting
- NCT06049186 — CRD vs. Met in Patients With Obese PCOS Infertility · NA · unknown
- NCT06104748 — A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR) · recruiting
- NCT05498558 — The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06096805 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai First Maternity and Infant Hospital
- Last refreshed: 7 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06096805.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing